Article Versions Notes

Zhang Q, Zhu H, Cui Z, Li Y, Zhuo J, Ye J, Zhang Z, Lian Z, Du Q, Zhao K-N, et al. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis. Biomolecules. 2022; 12(8):1114. https://doi.org/10.3390/biom12081114

Zhang, Qingyuan, Hua Zhu, Zhouying Cui, Yuxiao Li, Jiaying Zhuo, Jingwei Ye, Zhihui Zhang, Zheng Lian, Qianqian Du, Kong-Nan Zhao, and et al. 2022. "The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis" Biomolecules 12, no. 8: 1114. https://doi.org/10.3390/biom12081114

Zhang, Q., Zhu, H., Cui, Z., Li, Y., Zhuo, J., Ye, J., Zhang, Z., Lian, Z., Du, Q., Zhao, K.-N., Zhang, L., & Jiang, P. (2022). The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis. Biomolecules, 12(8), 1114. https://doi.org/10.3390/biom12081114